Resolve Biosciences

Resolve Biosciences provides a spatial biology platform called Molecular Cartography that enables multi-modal profiling of RNA, proteins, and tissue morphology at single-molecule resolution. The technology uses fluorescence in situ hybridization to characterize cellular neighborhoods and disease pathology without requiring signal amplification or tissue clearing. The company serves researchers in precision medicine and drug development by identifying spatially-resolved biomarkers and analyzing mechanisms of disease progression.